At close: January 2 at 4:00:01 PM EST
After hours: January 2 at 5:32:19 PM EST
Breakdown
TTM
12/31/2023
12/31/2022
12/31/2021
12/31/2020
Operating Cash Flow
-30,182.00
-17,932.00
-16,294.00
-19,487.00
-23,075.00
Investing Cash Flow
-3,648.00
-14.00
--
--
-15.00
Financing Cash Flow
-35.00
--
--
55,560.00
19,357.00
End Cash Position
5,413.00
20,821.00
38,757.00
55,070.00
19,025.00
Capital Expenditure
--
-14.00
--
--
-15.00
Issuance of Capital Stock
-50.00
--
--
55,041.00
9,062.00
Free Cash Flow
-30,182.00
-17,946.00
-16,294.00
-19,487.00
-23,090.00
12/31/2020 - 7/25/2013
Upgrade to begin using 40 years of financial statements and get so much more.
Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.
UpgradeRelated Tickers
NLSP NLS Pharmaceutics AG
2.1800
+3.32%
ABP Abpro Holdings, Inc.
1.5700
-12.29%
COEP Coeptis Therapeutics Holdings, Inc.
5.91
+7.45%
RAPT RAPT Therapeutics, Inc.
1.6300
+3.16%
PLRZ Polyrizon Ltd.
1.8300
-15.67%
SPRC SciSparc Ltd.
0.3926
+9.06%
APM Aptorum Group Limited
2.2000
-21.43%
ONCO Onconetix, Inc.
0.6511
+3.35%
VINC Vincerx Pharma, Inc.
0.2353
-10.46%
VSTM Verastem, Inc.
6.49
+25.53%